Clinical Trials Directory

Trials / Unknown

UnknownNCT05552248

Assessment of the Safety and Performance of a Lumbar Belt

Status
Unknown
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Decathlon SE · Industry
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

Decathlon has developed the Lumbar belt Soft 300 and Mid 500 products which are medical devices designed to reduce pain and improve function during sport practice for athletes with a common subacute or chronic low back pain. The objective of this multicentre study is to collect data on the related clinical complications and clinical outcomes of market-approved Decathlon Lumbar belt range of products to demonstrate safety and performance of these devices in a real-world setting. Outcome data collected from this study will provide the basis for Post-Market Surveillance (PMS) reporting, Clinical Study Report (CSR), Clinical Evaluation Report (CER) on Decathlon lumbar belt Soft 300/ Mid 500 devices and support peer-reviewed publications on products performance and safety.

Conditions

Interventions

TypeNameDescription
DEVICELumbarBelt SOFT 30015 patients will be included in this group and will used the medical device LumbarBelt SOFT 300 during sport practice (at least 2 sport sessions per week), for 12 weeks.
OTHERControl group LumbarBelt SOFT 30015 patients will be included in this control group and will performed their sport sessions as usual (without the medical device LumbarBelt SOFT 300), for at least 2 sport sessions per week during 12 weeks.
DEVICELumbarBelt MID 50015 patients will be included in this group and will used the medical device LumbarBelt MID 500 during sport practice (at least 2 sport sessions per week), for 12 weeks.
OTHERControl group LumbarBelt MID 50015 patients will be included in this control group and will performed their sport sessions as usual (without the medical device LumbarBelt MID 500), for at least 2 sport sessions per week during 12 weeks.

Timeline

Start date
2022-09-23
Primary completion
2023-12-01
Completion
2023-12-01
First posted
2022-09-23
Last updated
2023-01-17

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT05552248. Inclusion in this directory is not an endorsement.